NL-OMON23013已完成不适用
Double blind randomized intervention study aiming at reducing dexamethasone related side effects in children with acute lymphoblastic leukemia (ALL).
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Written informed consent;
- •2. Age 3-16;
排除标准
- •1. Patient or parent refusal;
- •2. Anticipated compliance problems;
研究者
相似试验
尚未招募
2 期
Comparison of Levobupivacaine with Fentanyl vs Ropivacaine with Fentanyl in Thoracic Epidural for post thoracotomy pain reliefCTRI/2020/07/026296Department of Anaesthesia SMS Medical College
尚未招募
不适用
Een dubbelblind gerandomiseerd onderzoek naar de doelmatigheid van cyclopentolaat 1% en cyclopentolaat 1% met tropicamide 1% bij kinderen. Afkorting: Doelmatigheid van cycloplegica.cycloplegia, residual accommodation, mydriasis, astigmatism, pupillary reaction to light, recupertion time.NL-OMON21701RvBMedical Centre HaaglandenPostbus 4322501 CK The HagueThe Netherlands419
尚未招募
3 期
To compare the effect of two different doses of drug known to prevent fall in blood pressure(ondansetron) in caesarean delivery by calculating the dose of injection of blood pressure raising medicine(ephedrine) required to control fall in blood pressure.CTRI/2023/08/057012Department of Anaesthesiology, SMS Medical College and attached Hospitals, Jaipur
已完成
不适用
Comparison between Dexmedetomidine and Magnesium sulphate for heart rate, blood pressure,intra-operative bleeding in functional endoscopic sinus surgeryCTRI/2019/11/021910SMS Medical College Jaipur60
招募中
不适用
Pharmacological treatment of Depression: Phase II Lithium addition.A double-blind, and randomized singlecenter trial comparing two treatment strategies in patients with a major depression. During phase I patients were treated during 7 weeks with: Imipramine or Venlafaxine. In phase II the non-responders of phase I will be treated with Lithium addition in an open trial during 4 weeks. During these 4 weeks the antidepressant drugs from phase I will be continued at the same dose under maintaining double-blind conditions.NL-OMON25557none69